Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.
This opinion article examines the concept of clinical justification for osteoporosis imaging, noting that advances in imaging and AI now permit opportunistic identification of osteoporosis and other conditions beyond the original scan purpose, and discusses how these opportunistic tools might eventually become standalone justified diagnostic pathways.
Researchers audited 5,000 archived liquid-based cytology cases and compared an interpretable machine learning pipeline, LBC-NET, to a double-blind panel of senior cytopathologists for detection of high-grade squamous intraepithelial lesions or worse, testing robustness across age and clinical subgroups.
On 2026-07-24, researchers described SynTabFall, a synthetic tabular health dataset of 745,380 samples and 44 attributes covering demographics, diseases, mobility and cognition risk factors for fall risk assessment. They reported that models trained on the synthetic data can reach predictive performance on par with models trained on real data, without requiring access to original patient records.
By July 2026, a narrative review of 127 peer-reviewed studies from 2015-2026 examined how AI and ML are being used in pharmaceutical research and healthcare. The review found the technologies enable large-scale biomedical data analysis and data-driven decision-making while simultaneously introducing interconnected ethical challenges.
On 2026-07-02, a peer-reviewed paper in AI & SOCIETY introduced Value-Sensitive Citizen Science (VSCS), a framework that combines Value-Sensitive Design with citizen science to involve community members as co-researchers in AI development. It uses the Participatory Value-Cognition Taxonomy and extended scenario reasoning to translate local values into technical requirements and embeds governance for lifecycle oversight.
Published July 17, 2026, this perspective argues that quantitative prediction of biomolecular recognition requires moving beyond static structures to ensemble-based thermodynamic and kinetic observables. It reviews physics-based sampling under approximate Hamiltonians and modern machine learning models that learn from structural and bioactivity data.
On 2026-07-17, a review in Physical Chemistry Chemical Physics summarized machine learning force fields for inorganic crystalline materials, describing how they combine first-principles accuracy with classical force-field efficiency to enable atomic-level studies across structural prediction, physical properties, defects and interfaces, and phase transitions.
On 2026-04-03, a peer-reviewed article reported a systematic review and bibliometric analysis of 627 articles on human-AI decision-making. The authors identified two critical dimensions, AI-human dynamics and decision typologies, and proposed a novel conceptual framework comprising four paradigms: adaptive intuitive, programmed algorithmic, interpretive analytical, and integrative hybrid decision-making.